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The aim of this study was to evaluate the effect of scaffolds native or polyanionic collagen matrix (submitted 
to alkaline treatment for 48 or 96 hours, PCM48 or PCM96, respectively) on the repair of osteoporosis bone 
fractures resulting from the gonadal hormone alterations caused by ovariectomy in rats undergoing hormone 
replacement therapy. The physical and mechanical characteristics of bone were analyzed. Macroscopic analysis 
revealed the absence of pathological alterations in the implanted areas. The percent mineral matter and bone 
mineral density of the femurs were lower in ovariectomized rats. The mechanical strength of newly formed bone 
was greater in the area receiving the PCM96 scaffolds compared to the area implanted with the native scaffolds. 
The PCM96 scaffold is the best choice for bone repair in animals with hormone deficiency since it promotes 
faster bone growth and good mechanical strength.
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1. Introduction
The ovary is an endocrine gland responsible for the production 
of estrogen and progesterone. A decrease in estrogen secretion 
is observed in cases of early menopause, late menarche1,2 and 
ovariectomy3. Deficiency in this hormone results in uncontrolled 
bone remodeling characterized by a decrease in osteoblastic 
activity and in bone matrix and reduced deposition of calcium 
and phosphorus in bone. These alterations can damage 
bone microarchitecture, predisposing to the occurrence of 
osteoporosis1,2.
Shen et al.3 demonstrated that a reduction of estrogen 
concentration in ovariectomized rats provoked a decrease in bone 
mineral density and biomechanical changes in the femur, two 
factors that are important for the prevention of pathological femoral 
fractures, the most feared event in osteoporosis. Pathological 
fractures are generally treated surgically by placement of a total 
prosthesis or by fixation with pins/screws depending on the type 
and severity of the fractures4.
Polyanionic collagen matrices implanted into experimental 
animals were found to cause no inflammatory response and 
presented good biocompatibility, and may represent a suitable 
alternative for bone implants5,6. However, studies have shown 
that the health status of bone is essential for its interaction 
with biomaterials7 and may alter the expected results. Pan 
et al.8 investigated the influence of estrogen deficiency on bone 
remodeling adjacent to hydroxyapatite implants in the tibia of 
ovariectomized rats and noted a decrease in both bone volume 
and implant-bone contact in the recipient area. Thus, osteoporosis 
might compromise the bone-implant interaction.
One approach to prevent the installation or even to treat 
osteoporosis is hormone replacement therapy. Although widely 
used, there are no data in the literature showing the possible effects 
of osteoporosis or hormone replacement therapy on bone-implant 
interactions9. In view of this fact and of the advantages offered by 
artificial collagen matrices, the objective of the present study was to 
evaluate the volume density of newly formed bone at the implant site 
and the mechanical strength and physical properties of femoral defects 
filled with polyanionic collagen scaffolds in rats with ovariectomy-
induced osteoporosis.
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2. Materials and Methods
2.1. Preparation of the artificial extracellular matrices
The raw material used for the preparation of the three-dimensional 
collagen scaffolds was bovine pericardium provided by Braile Biomédica 
S/A (São José do Rio Preto, SP, Brazil). The samples were prepared 
and provided by the Institute of Chemistry of São Carlos, University 
of São Paulo. The following samples were obtained: untreated 
native three-dimensional collagen matrices (NCM), and polyanionic 
three-dimensional collagen matrices obtained by alkaline treatment 
of the collagen matrix for 48 and 96 hours (PCM48 and PCM96, 
respectively).
2.2. Animals
Ninety-six adult female albino Wistar rats (Rattus norvegicus, 
12 weeks old), provided by the Multi-Institutional Animal House 
of the State University of Campinas, were used. The animals were 
divided into the following groups: group 1, non-ovariectomized 
animals (NO); group 2, unilaterally ovariectomized animals (UO); 
group 3, bilaterally ovariectomized animals not submitted to hormone 
replacement therapy (BOWHRT); group 4, bilaterally ovariectomized 
animals submitted to hormone replacement therapy (BOHRT). 
Each group was divided into three subgroups (n = 8 per subgroup) 
which received the NCM, PCM48 and PCM96 scaffold implants, 
respectively. The experimental procedure was approved by the Ethics 
Committee of the institution (CEPex, process 042/07).
2.3. Ovariectomy and hormone replacement therapy
The animals were weighed and anesthetized by intramuscular 
administration of a dose of 0.10 mg/100 g body weight ketamine 
(Francotar, Sespo Ind, Jacareí, SP, Brazil) and xylazine hydrochloride 
(2% Virbaxyl, Virbac Brasil, São Paulo, SP, Brazil) at a proportion 
of 1:1. A 2-cm incision was made in the skin with a scalpel lateral to 
the spine to completely remove both ovaries from the pelvic cavity. 
During the postoperative period the animals received dipyrone in 
water for 2 weeks. Estradiol hexahydrobenzoate (Benzogynestryl, 
Hoechst Marion Roussel, French) was used. The drug was diluted 
in peanut oil (All Chemistry, São Paulo, SP, Brazil) and the animals 
were injected subcutaneously with 20 µg at an average interval of 
48 hours from the time of scaffold implantation to the day of sacrifice 
after 8 weeks.
2.4. Surgical procedure for the implantation of the native 
and polyanionic collagen matrices
The scaffolds were implanted 4 months after ovariectomy. 
The animals were anesthetized as described above and an incision 
was made in the skin on the medial side of the thigh, exposing the 
femoral quadriceps muscle which was sectioned longitudinally in its 
distal third and separated anterolaterally. With the distal end of the 
diaphysis of the left femur exposed and the periosteum separated, a 
bone defect was created with a 5 mm surgical bur coupled to the pen 
of a mini-motor. Next, the defect was filled with the artificial matrices. 
The periosteum was repositioned and closed with No. 6.0 suture. The 
musculature and skin were closed with No. 4.0 suture.
The animals were sacrificed 8 weeks after implantation of the 
scaffold into the femur by intramuscular administration of an overdose 
of the anesthetic (ketamine/xylazine hydrochloride), followed by 
pneumothorax induced by sectioning of the diaphragm through the 
abdominal cavity. The femurs with the recipient area were removed, 
photographed and submitted to mechanical testing and subsequent 
analysis of their physical properties. Next, the samples were fixed in 
Karnovsky’s fixative, dehydrated in an increasing ethanol series, cleared 
in xylene, and embedded in Paraplast. Semi-serial 5 µm cross-sections 
were obtained and stained with hematoxylin and eosin.
2.5. Morphometric analysis
Using a square grid with 100 points coupled to the eyepiece of 
a light microscope, the volume density of newly formed bone at 
the site of the collagen implant was calculated for each recipient 
area. Newly formed bone was quantified by stereology according 
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= volume density or 
relative volume, P
P 
= number of points over newly formed bone, and 
P
T 
= total number of points of the system.
2.6. Analysis of the biomechanical properties of the femur
The biomechanical parameters were obtained by compression 
testing in an Instron 4444 Universal testing machine. A load cell with 
a maximum capacity of 1 kN was used. Before the test, the bones were 
thawed at room temperature and kept in saline until the time of the test. 
The bone was fixed to a support and force was applied perpendicularly 
to the longitudinal axis of the recipient area in the anteroposterior 
direction using a cylindric rod with a 3 mm roller fixed to its end. A 
pre-load of 5 N was initially used for accommodation. Next, the load 
was applied over the recipient area at a constant velocity of 2 mm/min 
until a 2 mm displacement of the support was observed, and the 
data were recorded. On the basis of these data, force-deformation 
curves were constructed for the different tests and the biomechanical 
parameters were determined using the Matlad software. Stress-strain 
curves were obtained for the different assays and the mechanical 
strength of bone can be calculated from these curves11.
2.7. Analysis of the physical properties of the femur
The femurs were kept in a desiccator for 24 hours, and the immersed 
weight (IW, weight of bone immersed in distilled water (Archimedes 
Principle)) and wet weight (WW, wet weight of bone after 24 hours in 
a desiccator) were then calculated. After this procedure, the bones were 
dehydrated in an oven at 100 °C for 24 hours and the dry weight (DW, 
weight of dehydrated bone after 24 hours at 100 °C) was calculated. 
For the determination of mineral composition, the bones were placed 
in a muffle furnace at 800 °C for 24 hours and the mineral weight 
(MW) was determined. Bone and mineral densities were obtained by 
calculation of the bone volume according to the Archimedes Principle. 
The bone percentages of water and mineral matter were also calculated 
using the following formulas12: bone volume = WW – IW (cm3)/water 
density; bone density = WW/bone volume (g.cm–3); bone mineral 
density = MW/bone volume (g.cm–3), and bone percentage of mineral 
matter = MW/WW (%). On the basis of the results of the biomechanical 
compression test and bone mineral density, bone quality was calculated 
using the following formula: S = F max / BMD, where S = maximum 
normalized force (bone quality) [N/(mg.mm–3)]; F max = maximum load 
applied to the recipient area until the occurrence of 2 mm displacement 
of the support [N], and BMD = bone mineral density (mg.mm–3).
2.8. Statistical analysis
Linear models were fitted to each of the response variables, with 
the response being the variable analyzed and the factors the group to 
which the animals belonged (NO, UO, BOWHRT and BOHRT) and 
the type of implant (NCM, PCM48 and PCM96). The model was also 
fitted considering the interaction between group and type of implant. 
Significance tests were applied to determine the effect of each factor 
on the response variable. The levels of significance (p < 0.05) were 
adjusted using the Tukey-Kramer test.
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3. Results
3.1. Macroscopic and quantitative analysis
In NO animals, the NCM and PCM48 implants presented a lower bone 





demonstrated macroscopically by the fact that the bone lesion created 




, arrows). In 
the case of the PCM96 implant, the lesion was partially closed and the 
implant was covered with periosteum (Figure 1a
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, arrow). Similar results 









respectively). Macroscopic analysis of BOHRT animals showed that, for 
the three implants studied, the lesions created continued to be partially 




, arrows). With 
respect to the quantity of newly formed bone in the implant area, lower 
bone formation was observed in the BOWHRT group, irrespective of the 
type of scaffold used. No significant difference in the morphometric data 
was observed between the NO, UO and BOHRT groups. In addition, the 
volume of newly formed bone was lower in areas receiving the NCM than 
in those treated with the polyanionic matrices (Figure 2).
3.2. Biomechanical properties
Figure 3 shows the mean maximum strength according to the 
type of implant (NCM, PCM48, and PCM96) and group (NO, UO, 
BOHRT, and BOWHRT). Analysis of this variable showed a highly 
Figure 1. Macroscopic analysis of the implant areas. NCM: native collagen 
matrix; PCM48: polyanionic collagen matrix submitted to alkaline treatment 
for 48 hours; PCM96: polyanionic collagen matrix submitted to alkaline 
treatment for 96 hours.
Figure 2. Mean quantity of newly formed bone determined by morphometric 
analysis. NCM: native collagen matrix; PCM48: polyanionic collagen matrix 
submitted to alkaline treatment for 48 hours; PCM96: polyanionic collagen 
matrix submitted to alkaline treatment for 96 hours; NO: non-ovariectomized 
animals; UO: unilaterally ovariectomized animals; BOWHRT: bilaterally 
ovariectomized animals not submitted to hormone replacement therapy; 
BOHRT: bilaterally ovariectomized animals submitted to hormone 
replacement therapy. p < 0.05 indicates statistical significance.
Figure 3. Mean mechanical strength of newly formed bone. NCM: native collagen 
matrix; PCM48: polyanionic collagen matrix submitted to alkaline treatment for 
48 hours; PCM96: polyanionic collagen matrix submitted to alkaline treatment 
for 96 hours; NO: non-ovariectomized animals; UO: unilaterally ovariectomized 
animals; BOWHRT: bilaterally ovariectomized animals not submitted to hormone 
replacement therapy; BOHRT: bilaterally ovariectomized animals submitted to 
hormone replacement therapy. p < 0.05 indicates statistical significance.
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significant group/implant interaction (p < 0.05). With respect to the 
NCM, a significant difference was observed between groups, except 
between the NO and UO groups and between the BOWRHT and 
BOHRT groups. No significant differences between groups were 
found for the PCM48 or PCM96. Comparison of the three matrices in 
each group showed no difference between the native and polyanionic 
scaffolds in the NO or UO group. In the BOWHRT and BOHRT 
groups, mechanical strength was greater in the area receiving the 
PCM96 scaffold compared to the area implanted with the NCM.
3.3. Physical properties
Percent mineral matter was lower in the BOWHRT group 
compared to the other groups (Figure 4a). No significant differences 
in mineral density were observed between groups (Figure 4b). For 
the bone quality, similar results occurred between NO and OU and 
between BOHRT and BOWHRT; however significant differences 
were found between NO/OU and BOHRT/BOWHRT (Figure 5a). 
Mean bone density was lower in the BOWHRT group compared to 
the other groups (Figure 5b).
4. Discussion
Previous studies from our group have shown that osteoblastic 
cells cultured on polyanionic collagen matrices are able to induce the 
biomineralization process in vitro13 and in vivo5,6. In addition, when 
implanted into nude animals, these polyanionic collagen matrices 
containing osteoblastic cells induce new bone formation in calvarial 
bone defects14. In view of the highly promising initial results of this 
material, we decided to study its behavior in a situation in which the 
recipient bone is of poor quality. In the present experimental model, 
osteoporotic bone was evaluated, which presents structural and 
mechanical characteristics distinct from those of healthy bone.
Functionally, the most important mechanical properties of bone 
are its strength and rigidity. These and other biometric features are 
best evaluated by analysis of their behavior under loads, i.e., under 
the influence of externally applied forces9,11. This fact becomes 
important when evaluating the quality of bone and of the synthetic 
graft material to be used for the treatment of pathological fractures, 
the most common complications of hormone deficiency-induced 
osteoporosis. Several studies have reported the deleterious effects 
of ovariectomy on bone properties, including reduced resistance to 
external mechanical forces11,15,16,17.
Figure 4. a) Mean percent mineral matter; and b) mineral density of bone 
in the different experimental groups. NO: non-ovariectomized animals; UO: 
unilaterally ovariectomized animals; BOWHRT: bilaterally ovariectomized 
animals not submitted to hormone replacement therapy; BOHRT: bilaterally 
ovariectomized animals submitted to hormone replacement therapy. 
p < 0.05 indicates statistical significance.
Figure 5. a) Mean bone quality and; b) mean bone density in the different 
experimental groups. NO: non-ovariectomized animals; UO: unilaterally 
ovariectomized animals; BOWHRT: bilaterally ovariectomized animals 
not submitted to hormone replacement therapy; BOHRT: bilaterally 
ovariectomized animals submitted to hormone replacement therapy. 
p < 0.05 indicates statistical significance.
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Hypoestrogenemia increases bone resorption and reduces 
trabecular bone mass, thus affecting the biomechanical strength of 
bone tissue18. This strength depends on bone structure, including 
the global geometry of bone and the microscopic pattern of the 
trabecular network19. Compared to normal bone, osteoporotic bone 
is characterized by a reduced number of trabeculae, trabecular 
thinning, and loss of trabecular connectivity. The overall result 
is a deterioration of bone strength and an increased fracture 
susceptibility20, however, these authors did not use any type of 
implant. Ozawa et al.17 used titanium implants to treat bone defects 
created in the femur of ovariectomized rats. Biomechanical tests 
performed 2 weeks later showed that the mechanical strength of the 
recipient area in ovariectomized rats was only half the value found in 
non-ovariectomized animals. In a recent study, Wang et al.21 induced 
an osteoporotic state for the evaluation of CaSO
4
 resorption and 
observed that ovariectomized animals exhibited pathological bone 
changes consistent with the osteoporosis phenotype. The authors 
suggested that these derangements in bone microarchitecture and 




In a previous study, we have shown that the quantity of newly 
formed bone was significantly lower in animals receiving the NCM 
compared to PCM48 and PCM96, but no data were obtained regarding 
the characteristics or quality of the bone formed22. In the present study, 
no difference in mechanical strength was observed between the groups 
receiving the polyanionic scaffolds despite a higher concentration of 
newly formed bone in non-ovariectomized animals. The rapid loss 
of metaphyseal trabecular bone as a result of the imbalance between 
bone resorption and formation caused by ovariectomy may had a 
negative influence on the mechanical quality of the recipient area in 
animals receiving the polyanionic scaffolds.
The mechanical strength of the areas implanted with the native 
scaffold was higher in intact animals compared to ovariectomized 
rats not submitted to hormone replacement therapy. However, an 
increase in bone strength and rigidity does not necessarily indicate 
improvement in the biomechanical properties of bone tissue23. We 
therefore used a three-point bending biomechanical test. According to 
Keller and Spengler24, in this test bone deformation is due to changes 
in angular length or shape. This deformation does not exceed 3% 
considering the elastic amplitude of the stress-strain curve because 
bone restores its original shape or length after the load is removed. 
If load application is continued, the bone tissue reaches its point of 
deformation followed by rupture, a phase called plastic or non-elastic 
phase. In the present study, the bone sample contained an implant 
and we therefore chose to perform a compression test at the implant 
site. In the three-point bending test, fracture generally occurs in the 
proximal part, whereas in the present case the implant was located 
in the distal part. The load for accommodation of the sample should 
not exceed 10% of the maximal load; therefore, 5 N was used which 
was sufficient to accommodate the sample.
Trabecular architecture is an important factor in osteoporosis 
and has been quantified by mean of many parameters. However, 
variations within specimens have been largely ignored. Furthermore, 
age, disease or drug treatment increases variations in trabecular 
thickness, which might interfere with the mechanical properties of 
bone25. Comparison of the scaffolds within each group showed no 
difference in the NO or UO group, whereas a difference was observed 
in the BOHRT and BOWHRT groups, with the area receiving the 
PCM96 scaffold presenting greater strength than the area implanted 
with the native scaffold.
According to Lepola et al.26, bone mineral content is one of 
the determinants of biomechanical bone strength and ovariectomy 
causes a loss of bone mineral content, especially in trabecular areas27. 
Katsumata et al.23 and Shen et al.3 observed a decrease of bone mineral 
content and density in the femur of ovariectomized rats compared 
to the intact group, but there was no difference between groups in 
terms of fracture resistance or rigidity. Wang et al.25 evaluated the 
influence of osteoporosis on the middle and late periods of tibia 
fracture healing in ovariectomized rats, analyzing histomorphological 
changes, bone mineral density and biomechanical properties. In 
that study, bone mineral density and callus failure stress were 
lower in the ovariectomized group compared to the sham group. In 
the present study, a decrease in bone mineral density and percent 
mineral matter was observed in ovariectomized rats not submitted 
to hormone replacement therapy, but these animals did not differ in 
terms of mechanical strength of the area receiving the polyanionic 
scaffolds.
Ovariectomized animals are frequently used as models in the 
study of postmenopausal osteoporosis; however, some discrepancies 
exist in the literature regarding bone-implant interaction when 
biomaterials such as titanium and ceramics are used. For example, 
some studies reported significant bone loss around these biomaterials, 
whereas others found no difference in bone growth in the recipient 
areas of ovariectomized animals17. Differences in the results 
of human studies have also been reported. In a study involving 
30 postmenopausal women ranging in age from 46 to 62 years with 
a diagnosis of osteoporosis and alveolar bone defects, a biphasic 
calcium phosphate/poly-DL-lactide-co-glycolide (BCP/PLGA) 
composite was implanted into the osteoporotic alveolar bone. Six 
weeks after implantation, bone density was lower in the region of 
osteoporotic bone receiving the implant than in untreated control 
bone. On the other hand, 24 weeks after implantation bone density 
was significantly higher when compared to the untreated region28.
Analysis of some physical properties of the femurs revealed a 
significant difference between intact animals and ovariectomized rats 
not submitted to hormone replacement therapy. Similar results have 
been reported by Hietala29 and Nordsletten et al.16 who observed a 
reduction in femoral bone density and volume in ovariectomized 
rats. However, in the present study bone volume was higher in 
ovariectomized animals not submitted to hormone replacement 
therapy, although wet weight, a variable used to calculate bone 
volume and density, was similar in the groups. Controversial data 
regarding the lack of change in wet weight have also been reported 
in other studies11,16.
In the present experiment, macroscopic and quantitative analyses 
showed that the sites receiving the polyanionic collagen matrices 
(PCM48 and PCM96) presented the best interaction and capacity of 
bone neoformation when compared to areas implanted with the native 
collagen scaffold. In addition, in ovariectomized rats bone strength 
was greater in areas implanted with the PCM96 scaffold.
The present findings are also compatible with previous results 
from our group showing a significant advantage of PCM96 compared 
to other scaffolds when implanted into animals with experimentally 
induced osteoporosis22. However, it is not sufficient that these implants 
induce bone formation. It is also necessary that this newly formed 
bone is of good quality, i.e., its strength is compatible with that of 
normal bone. In the present study, bone tissue of satisfactory quality 
was obtained with the PCM96 matrix in all situations studied. The 
PCM48 matrix also promoted fairly good mechanical strength, except 
for animals with experimental osteoporosis.
The present results suggest that polyanionic scaffolds are a 
promising biomaterial for the regeneration of bone defects due to 
their qualities. In cases of osteoporosis due to hormone deficiency, the 
PCM96 scaffold is the best choice for bone repair since it promotes 
faster bone growth and good mechanical strength.
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